{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:47:59Z","timestamp":1790416079787,"version":"4.1.0"},"reference-count":61,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,24]]},"DOI":"10.18632\/oncotarget.12535","type":"journal-article","created":{"date-parts":[[2016,10,8]],"date-time":"2016-10-08T19:50:05Z","timestamp":1475956205000},"page":"7059-7067","source":"Crossref","is-referenced-by-count":19,"title":["The IgH 3\u2019 regulatory region and c-myc-induced B-cell lymphomagenesis"],"prefix":"10.18632","volume":"8","author":[{"given":"Nour","family":"Ghazzaui","sequence":"first","affiliation":[{"name":"Universit\u00e9 de Limoges, Centre National de la Recherche Scientifique, CNRS UMR, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Saintamand","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Limoges, Centre National de la Recherche Scientifique, CNRS UMR, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein","family":"Issaoui","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Limoges, Centre National de la Recherche Scientifique, CNRS UMR, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Vincent-Fabert","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Limoges, Centre National de la Recherche Scientifique, CNRS UMR, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Denizot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Limoges, Centre National de la Recherche Scientifique, CNRS UMR, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev.immunol.16.1.163","article-title":"Transcription regulation during B cell development","volume":"16","author":"Calame","year":"1998","journal-title":"Ann Rev Immunol"},{"key":"2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-387663-8.00002-8","article-title":"The IgH locus 3\u2019 regulatory region: pulling the strings from behind","volume":"110","author":"Cogn\u00e9","year":"2011","journal-title":"Adv Immunol"},{"key":"3","first-page":"457","article-title":"MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications","volume":"1846","author":"Juszczynski","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"4","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/15384101.2015.1010964","article-title":"3\u2019RR targeting in lymphomagenesis: a promising strategy?","volume":"14","author":"Denizot","year":"2015","journal-title":"Cell Cycle"},{"key":"5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4049\/jimmunol.1302868","article-title":"The E\u03bc enhancer region influences H chain expression and B cell fate without impacting IgVH repertoire and immune response in vivo","volume":"193","author":"Pinaud","year":"2014","journal-title":"J Immunol"},{"key":"6","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1084\/jem.20130072","article-title":"The IgH 3\u2019 regulatory region controls AID-induced somatic hypermutation in germinal centre B-cells in mice","volume":"210","author":"Denizot","year":"2013","journal-title":"J Exp Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"10730","DOI":"10.1038\/ncomms10730","article-title":"Deciphering the importance of the palindromic architecture of the immunoglobulin heavy chain 3\u2019 regulatory region","volume":"7","author":"Denizot","year":"2016","journal-title":"Nature Commun"},{"key":"8","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1182\/blood-2010-01-264689","article-title":"Genomic deletion of the whole IgH 3\u2019 regulatory region (hs3a, hs1,2, hs3b, hs4) dramatically affects class switch recombination and Ig secretion to all isotypes","volume":"116","author":"Denizot","year":"2010","journal-title":"Blood"},{"key":"9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20131385","article-title":"Elucidation of the enigmatic IgD class switch recombination via germ-line deletion of the IgH 3\u2019 regulatory region","volume":"211","author":"Denizot","year":"2014","journal-title":"J Exp Med"},{"key":"10","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1038\/ncomms8084","article-title":"Elucidation of IgH 3\u2019 region regulatory role during class switch recombination via germline deletion","volume":"6","author":"Denizot","year":"2015","journal-title":"Nature Commun"},{"key":"11","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.18632\/oncotarget.3010","article-title":"The IgH 3\u2019 regulatory region governs \u03bc chain transcription in mature B lymphocytes and the B cell fate","volume":"6","author":"Denizot","year":"2015","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"crossref","first-page":"8356","DOI":"10.1074\/jbc.M112.341024","article-title":"Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b and hs4) are dispensable for diversity of VDJ recombination","volume":"287","author":"Denizot","year":"2012","journal-title":"J Biol Chem"},{"key":"13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2148-11-71","article-title":"Position and sequence conservation in Amniota of polymorphic enhancer HS1,2 within the palindrome of IgH 3\u2019 regulatory region","volume":"11","author":"Frezza","year":"2011","journal-title":"BMC Evol Biol"},{"key":"14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0996-15","article-title":"Palindromic structure of the IgH 3\u2019 locus control region","volume":"14","author":"Cogn\u00e9","year":"1996","journal-title":"Nature Genet"},{"key":"15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0378-1119(98)00475-2","article-title":"Insertion of the IgH locus 3\u2019 regulatory palindrome in expression vectors warrants sure and efficient expression in stable B cell transfectants","volume":"222","author":"Cogn\u00e9","year":"1998","journal-title":"Gene"},{"key":"16","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1073\/pnas.1514090113","article-title":"Sequential activation and distinct functions for distal and proximal modules within the IgH 3\u2019RR region","volume":"113","author":"Alt","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"17","doi-asserted-by":"crossref","first-page":"10730","DOI":"10.1038\/ncomms10730","article-title":"Deciphering the functional importance of the palindromic architecture of the immunoglobulin heavy chain 3\u2019 regulatory region","volume":"7","author":"Denizot","year":"2016","journal-title":"Nature Commun"},{"key":"18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Brinster","year":"1985","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Byrd","year":"2004","journal-title":"Blood"},{"key":"20","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1074\/jbc.M412446200","article-title":"Regulatory elements in the immunoglobulin heavy chain gene 3\u2019-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells","volume":"280","author":"Boxer","year":"2005","journal-title":"J Biol Chem"},{"key":"21","doi-asserted-by":"crossref","first-page":"6033","DOI":"10.4049\/jimmunol.179.9.6033","article-title":"The 3\u2019 IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype","volume":"179","author":"Denizot","year":"2007","journal-title":"J Immunol"},{"key":"22","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1016\/j.leukres.2009.05.018","article-title":"Genetic background modulates susceptibility to oncogen-driven proliferation and lymphoma occurrence in mice carrying a deregulated c-myc transgene","volume":"33","author":"Denizot","year":"2009","journal-title":"Leuk Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/8751","article-title":"Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in \u03b2-islet cell hyperplasia","volume":"22","author":"Barbacid","year":"1999","journal-title":"Nature Genet"},{"key":"24","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.ajpath.2012.01.004","article-title":"A defect of the INK4-Cdk4 checkpoint and c-myc collaborate in blastoid mantle cell lymphoma (MCL)-like lymphoma formation in mice","volume":"180","author":"Denizot","year":"2012","journal-title":"Am J Pathol"},{"key":"25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.bbrc.2005.03.189","article-title":"The transcriptional targets of p53 in apoptosis control","volume":"331","author":"Zhang","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cell.2006.12.007","article-title":"Modeling the therapeutic efficacy of p53 restoration in tumors","volume":"127","author":"Evan","year":"2006","journal-title":"Cell"},{"key":"27","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.4049\/jimmunol.1102059","article-title":"A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3\u2019 regulatory region-driven c-myc transgene","volume":"187","author":"Denizot","year":"2011","journal-title":"J Immunol"},{"key":"28","doi-asserted-by":"publisher","first-page":"586","DOI":"10.18632\/oncotarget.474","article-title":"Mantle cell lymphoma-like lymphomas in c-myc-3\u2019RR\/p53+\/- mice and c-myc-3\u2019RR\/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin","volume":"3","author":"Denizot","year":"2012","journal-title":"Oncotarget"},{"key":"29","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1073\/pnas.0912393107","article-title":"Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation","volume":"107","author":"Cogn\u00e9","year":"2010","journal-title":"Proc Nat Acad Sci USA"},{"key":"30","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.18632\/oncotarget.2297","article-title":"The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model","volume":"15","author":"Cogn\u00e9","year":"2014","journal-title":"Oncotarget"},{"key":"31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/leu.2010.302","article-title":"The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma","volume":"25","author":"Jardin","year":"2011","journal-title":"Leukemia"},{"key":"32","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","article-title":"Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants","volume":"101","author":"Bataille","year":"2003","journal-title":"Blood"},{"key":"33","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1158\/0008-5472.CAN-04-0268","article-title":"Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice","volume":"65","author":"Ried","year":"2005","journal-title":"Cancer Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1476-4598-9-97","article-title":"NF-kappaB\/STAT3\/PI3K signaling crosstalk in iMyc E mu B lymphoma","volume":"9","author":"Janz","year":"2010","journal-title":"Mol Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1158\/0008-5472.CAN-05-1222","article-title":"Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice","volume":"65","author":"Janz","year":"2005","journal-title":"Cancer Res"},{"key":"36","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1038\/bcj.2016.6","article-title":"KSHV-encoded vIL6 collaborates with deregulated c-MYC to drive plasmablastic neoplasm in mice","volume":"6","author":"Janz","year":"2016","journal-title":"Blood Cancer J"},{"key":"37","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI200420369","article-title":"Novel targeted deregulation of c-myc cooperates with Bcl-XL to cause plasma cell neoplasms in mice","volume":"113","author":"Janz","year":"2004","journal-title":"J Clin Invest"},{"key":"38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dnarep.2006.05.017","article-title":"Myc translocations in B cell and plasma cell neoplasms","volume":"5","author":"Janz","year":"2006","journal-title":"DNA Repair"},{"key":"39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1084\/jem.188.8.1421","article-title":"Class switching in B cells lacking 3\u2019 immunoglobulin. heavy chain enhancers","volume":"188","author":"Alt","year":"1998","journal-title":"J Exp Med"},{"key":"40","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.4049\/jimmunol.0901978","article-title":"vivo redundant function of the 3\u2019 IgH regulatory element HS3b in the mouse","volume":"184","author":"In","year":"2010","journal-title":"J Immunol"},{"key":"41","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.4049\/jimmunol.0900214","article-title":"Ig synthesis and class switching do not require the presence of the hs4 enhancer in the 3\u2019 IgH regulatory region","volume":"182","author":"Denizot","year":"2009","journal-title":"J Immunol"},{"key":"42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1074-7613(01)00181-9","article-title":"Localization of the 3\u2019 IgH locus elements that effect long-distance regulation of class switch recombination","volume":"15","author":"Cogn\u00e9","year":"2001","journal-title":"Immunity"},{"key":"43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nature08633","article-title":"Long-range oncogenic activation of IgH-c-myc translocations by the IgH 3\u2019 regulatory region","volume":"462","author":"Alt","year":"2009","journal-title":"Nature"},{"key":"44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1084\/jem.192.8.1183","article-title":"Burkitt lymphoma in the mouse","volume":"192","author":"Morse","year":"2000","journal-title":"J Exp Med"},{"key":"45","doi-asserted-by":"publisher","first-page":"20302","DOI":"10.18632\/oncotarget.3963","article-title":"The IgH 3\u2019 regulatory region influences lymphomagenesis in Ig\u03bb-Myc mice","volume":"6","author":"Denizot","year":"2015","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.immuni.2007.09.007","article-title":"S-S synapsis during class switch recombination is promoted by distantly located transcriptional elements and activation-induced deaminase","volume":"27","author":"Kenter","year":"2007","journal-title":"Immunity"},{"key":"47","doi-asserted-by":"crossref","first-page":"35169","DOI":"10.1074\/jbc.M705719200","article-title":"Evidence for physical interaction between the immunoglobulin heavy chain variable region and the 3\u2019 regulatory region","volume":"282","author":"Birshtein","year":"2007","journal-title":"J Biol Chem"},{"key":"48","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/leu.2011.115","article-title":"The immunoglobulin heavy chain gene 3\u2019 enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells","volume":"25","author":"Boxer","year":"2011","journal-title":"Leukemia"},{"key":"49","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1202882109","article-title":"Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus","volume":"109","author":"Dunnick","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"50","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1182\/blood-2013-06-510511","article-title":"Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma","volume":"123","author":"Ribrag","year":"2014","journal-title":"Blood"},{"key":"51","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1073\/pnas.91.11.4915","article-title":"LR1 regulates c-myc transcription in B-cell lymphomas","volume":"91","author":"Maizels","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1044-579X(02)00058-5","article-title":"Role of genetic and epigenetic changes in Burkitt lymphoma","volume":"12","author":"Wiman","year":"2002","journal-title":"Semin Cancer Biol"},{"key":"53","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1182\/blood-2012-12-473439","article-title":"A transgenic mouse model demonstrating the oncogenic role of mutations in the polycomb-group gene EZH2 in lymphomagenesis","volume":"123","author":"Umlandt","year":"2014","journal-title":"Blood"},{"key":"54","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10637-015-0206-x","article-title":"Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia","volume":"33","author":"Ribrag","year":"2015","journal-title":"Invest. New drugs"},{"key":"55","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.clml.2013.03.016","article-title":"Histone deacetylase inhibitors in multiple myeloma: rationale and evidence for their use in combination therapy","volume":"13","author":"Richardson","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"56","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.leukres.2013.03.006","article-title":"Preclinical data and early clinical experience supporting the use of histone deacetylase inhibitors in multiple myeloma","volume":"37","author":"Anderson","year":"2013","journal-title":"Leuk Res"},{"key":"57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tox.2009.03.015","article-title":"Diverse chemicals including aryl hydrocarbon receptor ligands modulate transcriptional activity of the 3\u2019 immunoglobulin heavy chain regulatory region","volume":"261","author":"Sulentic","year":"2009","journal-title":"Toxicology"},{"key":"58","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bbrc.2005.02.147","article-title":"Histone deacetylase inhibitor trichostatin A reduces anti-DNA autoantibody production and represses IgH gene transcription","volume":"330","author":"Sun","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"59","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.1200106109","article-title":"Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation","volume":"109","author":"Nussenzweig","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"60","doi-asserted-by":"publisher","first-page":"591","DOI":"10.18632\/oncoscience.81","article-title":"Targeting the oncogene B lymphoma deregulator IgH 3\u2019 regulatory region does not impede the in vivo inflammatory response in mice","volume":"1","author":"Denizot","year":"2014","journal-title":"Oncoscience"},{"key":"61","doi-asserted-by":"publisher","first-page":"38741","DOI":"10.18632\/oncotarget.9588","article-title":"Efficient role of IgH 3\u2019 regulatory region deficient B-cells in the development of oil granulomas","volume":"7","author":"Denizot","year":"2016","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:22:39Z","timestamp":1596720159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,8]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1,24]]}},"alternative-id":["12535","27729620"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12535","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,8]]}}}